Laura Cannella

1.1k total citations
37 papers, 483 citations indexed

About

Laura Cannella is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Laura Cannella has authored 37 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 22 papers in Genetics and 10 papers in Rheumatology. Recurrent topics in Laura Cannella's work include Chronic Lymphocytic Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Acute Myeloid Leukemia Research (14 papers). Laura Cannella is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Acute Myeloid Leukemia Research (14 papers). Laura Cannella collaborates with scholars based in Italy, United Kingdom and United States. Laura Cannella's co-authors include Fabio Efficace, Massimo Breccia, Giuliana Alimena, Francesco Dazzi, Roberto Latagliata, Vincenzo Mirenda, Caterina Stefanizzi, Anna Maria Frustaci, Michelina Santopietro and Ida Carmosino and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Laura Cannella

37 papers receiving 477 citations

Peers

Countries citing papers authored by Laura Cannella

Since Specialization

Citations

This map shows the geographic impact of Laura Cannella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cannella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cannella more than expected).

Fields of papers citing papers by Laura Cannella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cannella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cannella. The network helps show where Laura Cannella may publish in the future.

Co-authorship network of co-authors of Laura Cannella

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cannella. A scholar is included among the top collaborators of Laura Cannella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cannella. Laura Cannella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates 2024 ·Journal of Controlled Release ·(unknown), (unknown), Antonella Grigoletto, (unknown), Laura Cannella, Daniela Gabbia, (unknown), Akira Suzuki, Hiroki Yoshioka, Andrea Armirotti, Sara De Martin, Gianfranco Pasut	7
2	Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review 2020 ·The Lancet Haematology ·Rajshekhar Chakraborty, Laura Cannella, Francesco Cottone, Fabio Efficace	32
3	A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol 2018 ·Health and Quality of Life Outcomes ·Fabio Efficace, Mario Boccadoro, Antonio Palumbo, Maria Teresa Petrucci, Francesco Cottone, Laura Cannella, Elena Zamagni, Pasquale Niscola, Charalampia Kyriakou, Tommaso Caravita, Massimo Offidani, Franco Mandelli, Michèle Cavo	14
4	Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma – a case report 2015 ·Scientific Reports ·Alicja Gruszka, Cristina Rabascio, Laura Cannella, Simona Sammassimo, Giovanna Andreola, Giuliana Gregato, Mario Faretta, Angelica Calleri, (unknown), Giancarlo Pruneri, Francesco Bertolini, Myriam Alcalay	2
5	Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients 2010 ·Leukemia Research ·Massimo Breccia, Vincenzo Federico, Roberto Latagliata, (unknown), Gianna Maria D’Elia, Laura Cannella, Giuseppina Loglisci, Adriano Salaroli, Michelina Santopietro, Giuliana Alimena	26
6	Deferasirox Treatment Interruption in a Transfusion-Requiring Myelodysplastic Patient Led to Loss of Erythroid Response 2010 ·Acta Haematologica ·Massimo Breccia, Giuseppina Loglisci, Adriano Salaroli, Laura Cannella, Michelina Santopietro, Giuliana Alimena	18
7	“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia 2010 ·Leukemia Research ·Roberto Latagliata, Massimo Breccia, Ida Carmosino, Laura Cannella, (unknown), (unknown), Anna Maria Frustaci, Giuseppina Loglisci, Marco Mancini, Michelina Santopietro, Caterina Stefanizzi, (unknown), Federico Vozella, Giuliana Alimena	35
8	Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard dose 2009 ·Hematological Oncology ·Massimo Breccia, Laura Cannella, Caterina Stefanizzi, Roberto Latagliata, Mauro Nanni, Daniela Diverio, Michelina Santopietro, Vincenzo Federico, Giuliana Alimena	10
9	Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem? 2009 ·Cancer Chemotherapy and Pharmacology ·Massimo Breccia, Anna Maria Frustaci, Laura Cannella, Simona Soverini, Caterina Stefanizzi, Vincenzo Federico, Sara Grammatico, Michelina Santopietro, Giuliana Alimena	7
10	Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease 2008 ·Leukemia Research ·Massimo Breccia, Laura Cannella, Caterina Stefanizzi, Michelina Santopietro, (unknown), Daniela Diverio, Giuliana Alimena	1
11	Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: Further evidence for the arbitrary nature of current classification systems 2008 ·Leukemia & lymphoma ·Massimo Breccia, Laura Cannella, Anna Maria Frustaci, Caterina Stefanizzi, (unknown), Giuliana Alimena	4
12	Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia 2008 ·Leukemia & lymphoma ·Massimo Breccia, Caterina Stefanizzi, Laura Cannella, Roberto Latagliata, Anna Maria Frustaci, Ida Carmosino, Michelina Santopietro, Giuliana Alimena	13
13	Nilotinib Can Override Dasatinib Resistance in Chronic Myeloid Leukemia Patients with Secondary Resistance to Imatinib First-Line Therapy 2007 ·Acta Haematologica ·Massimo Breccia, Laura Cannella, Mauro Nanni, Caterina Stefanizzi, Giuliana Alimena	8
14	Ocular side effects in chronic myeloid leukemia patients treated with imatinib 2007 ·Leukemia Research ·Massimo Breccia, Fabiana Gentilini, Laura Cannella, Roberto Latagliata, Ida Carmosino, Anna Maria Frustaci, Giuliana Alimena	31
15	Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib 2007 ·Leukemia Research ·Massimo Breccia, Laura Cannella, Daniela Diverio, (unknown), Mauro Nanni, Caterina Stefanizzi, (unknown), Sergio Mecarocci, Giuliana Alimena	11
16	The highway code of T cell trafficking 2007 ·The Journal of Pathology ·(unknown), Laura Cannella, Francesco Dazzi, Vincenzo Mirenda	65
17	Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma 2007 ·Leukemia Research ·Massimo Breccia, Maurizio Martelli, Laura Cannella, Eleonora Russo, Erica Finolezzi, Caterina Stefanizzi, Anna Levi, Anna Maria Frustaci, Giuliana Alimena	8
18	The Effect of Total Knee Arthroplasty on Body Weight 2005 ·Orthopedics ·Gwo‐Chin Lee, Fred D. Cushner, Laura Cannella, W. Norman Scott	4
19	Correction of severe anaemia using immuno‐regulated gene therapy is achieved by restoring the early erythroblast compartment 2005 ·British Journal of Haematology ·(unknown), Katalin Takács, Patrick H. Maxwell, Irene Roberts, Francesco Dazzi, Laura Cannella, Matthias Merkenschlager, Amanda G. Fisher	2
20	Minor histocompatibility antigens and stem cell transplantation 2004 ·Vox Sanguinis ·R. Laylor, Laura Cannella, Elizabeth Simpson, Francesco Dazzi	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact